FAZYX
Price
$15.82
Change
-$0.10 (-0.63%)
Updated
Oct 7 closing price
Net Assets
3.15B
RLBAX
Price
$38.56
Change
-$0.09 (-0.23%)
Updated
Oct 7 closing price
Net Assets
266.1B
Interact to see
Advertisement

FAZYX vs RLBAX

Header iconFAZYX vs RLBAX Comparison
Open Charts FAZYX vs RLBAXBanner chart's image
Fidelity Advisor Multi-Asset Income M
Price$15.82
Change-$0.10 (-0.63%)
VolumeN/A
Net Assets3.15B
American Funds American Balanced R1
Price$38.56
Change-$0.09 (-0.23%)
VolumeN/A
Net Assets266.1B
FAZYX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
FAZYX vs. RLBAX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAZYX is a Buy and RLBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 266B vs. FAZYX (3.15B). FAZYX pays higher dividends than RLBAX: FAZYX (3.52) vs RLBAX (1.10). FAZYX was incepted earlier than RLBAX: FAZYX (10 years) vs RLBAX (23 years). RLBAX (1.31) is less costly to investors than FAZYX (1.08). FAZYX is a more actively managed with annual turnover of: 230.00 vs. RLBAX (44.00). FAZYX has a lower initial minimum investment than RLBAX: FAZYX (0) vs RLBAX (250). FAZYX annual gain was more profitable for investors over the last year : 15.33 vs. RLBAX (9.12). FAZYX return over 5 years is better than : 55.14 vs. RLBAX (38.04).
FAZYXRLBAXFAZYX / RLBAX
Total Expense Ratio1.081.3182%
Annual Report Gross Expense Ratio1.081.3182%
Fund Existence10 years23 years-
Gain YTD15.94013.770116%
Front Load4%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.15B266B1%
Annual Yield % from dividends3.521.10320%
Returns for 1 year15.339.12168%
Returns for 3 years46.5447.9897%
Returns for 5 years55.1438.04145%
Returns for 10 years118.9168.72173%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLY38.330.03
+0.09%
John Wiley & Sons
ROIV16.12-0.14
-0.86%
Roivant Sciences Ltd
PRLD1.44-0.02
-1.37%
Prelude Therapeutics
IVP0.98-0.03
-3.18%
Inspire Veterinary Partners Inc
GRRR19.99-0.68
-3.29%
Gorilla Technology Group